Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

In Silico and In Vitro Considerations of Keratinocyte Nuclear Receptor Protein Structural Order for Improving Experimental Analysis.

Shamilov R, Staid MJ, Aneskievich BJ.

Methods Mol Biol. 2020;2109:93-111. doi: 10.1007/7651_2019_240.

PMID:
31124000
2.

TNIP1 in Autoimmune Diseases: Regulation of Toll-like Receptor Signaling.

Shamilov R, Aneskievich BJ.

J Immunol Res. 2018 Oct 3;2018:3491269. doi: 10.1155/2018/3491269. eCollection 2018. Review.

3.

TNIP1 reduction sensitizes keratinocytes to post-receptor signalling following exposure to TLR agonists.

Rudraiah S, Shamilov R, Aneskievich BJ.

Cell Signal. 2018 May;45:81-92. doi: 10.1016/j.cellsig.2018.02.004. Epub 2018 Feb 5.

PMID:
29413846
4.

Interleukin-17 signaling triggers degradation of the constitutive NF-κB inhibitor ABIN-1.

Cruz JA, Childs EE, Amatya N, Garg AV, Beyaert R, Kane LP, Aneskievich BJ, Ma A, Gaffen SL.

Immunohorizons. 2017 Sep;1(7):133-141. doi: 10.4049/immunohorizons.1700035.

5.

TNIP1 reduction of HSPA6 gene expression occurs in promoter regions lacking binding sites for known TNIP1-repressed transcription factors.

Ramirez VP, Krueger W, Aneskievich BJ.

Gene. 2015 Jan 25;555(2):430-7. doi: 10.1016/j.gene.2014.11.012. Epub 2014 Nov 12.

6.

Basal and stress-inducible expression of HSPA6 in human keratinocytes is regulated by negative and positive promoter regions.

Ramirez VP, Stamatis M, Shmukler A, Aneskievich BJ.

Cell Stress Chaperones. 2015 Jan;20(1):95-107. doi: 10.1007/s12192-014-0529-0. Epub 2014 Jul 30.

7.

Transgene delivery to cultured keratinocytes via replication-deficient adenovirus vectors.

Ramirez VP, Aneskievich BJ.

Methods Mol Biol. 2014;1195:43-8. doi: 10.1007/7651_2013_43.

PMID:
24281865
8.

Sp sites contribute to basal and inducible expression of the human TNIP1 (TNFα-inducible protein 3-interacting protein 1) promoter.

Encarnacao PC, Ramirez VP, Zhang C, Aneskievich BJ.

Biochem J. 2013 Jun 15;452(3):519-29. doi: 10.1042/BJ20121666.

PMID:
23464785
9.

Human TNFα-induced protein 3-interacting protein 1 (TNIP1) promoter activation is regulated by retinoic acid receptors.

Gurevich I, Zhang C, Francis N, Struzynsky CP, Livings SE, Aneskievich BJ.

Gene. 2013 Feb 15;515(1):42-8. doi: 10.1016/j.gene.2012.11.041. Epub 2012 Dec 8.

10.

Organotypic modeling of human keratinocyte response to peroxisome proliferators.

Zhang C, Gurevich I, Aneskievich BJ.

Cells Tissues Organs. 2012;196(5):431-41. doi: 10.1159/000336268. Epub 2012 Jun 5.

11.

Emerging roles for TNIP1 in regulating post-receptor signaling.

Ramirez VP, Gurevich I, Aneskievich BJ.

Cytokine Growth Factor Rev. 2012 Jun;23(3):109-18. doi: 10.1016/j.cytogfr.2012.04.002. Epub 2012 Apr 28. Review.

12.

TNIP1, a retinoic acid receptor corepressor and A20-binding inhibitor of NF-κB, distributes to both nuclear and cytoplasmic locations.

Gurevich I, Zhang C, Francis N, Aneskievich BJ.

J Histochem Cytochem. 2011 Dec;59(12):1101-12. doi: 10.1369/0022155411427728.

13.

PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1.

Gurevich I, Zhang C, Encarnacao PC, Struzynski CP, Livings SE, Aneskievich BJ.

Biochim Biophys Acta. 2012 Jan;1819(1):1-15. doi: 10.1016/j.bbagrm.2011.09.006. Epub 2011 Oct 7.

14.

TNIP1 is a corepressor of agonist-bound PPARs.

Flores AM, Gurevich I, Zhang C, Ramirez VP, Devens TR, Aneskievich BJ.

Arch Biochem Biophys. 2011 Dec 1;516(1):58-66. doi: 10.1016/j.abb.2011.08.014. Epub 2011 Sep 22.

15.

Scanning for transcription factor binding by a variant EMSA.

Gurevich I, Zhang C, Aneskievich BJ.

Methods Mol Biol. 2010;585:147-58. doi: 10.1007/978-1-60761-380-0_11.

PMID:
19908002
16.

Liganded RARalpha and RARgamma interact with but are repressed by TNIP1.

Gurevich I, Aneskievich BJ.

Biochem Biophys Res Commun. 2009 Nov 20;389(3):409-14. doi: 10.1016/j.bbrc.2009.08.159. Epub 2009 Sep 2.

17.

Corepressors of agonist-bound nuclear receptors.

Gurevich I, Flores AM, Aneskievich BJ.

Toxicol Appl Pharmacol. 2007 Sep 15;223(3):288-98. Epub 2007 Jun 14. Review.

18.

Enzyme association with PPARgamma: evidence of a new role for 15-lipoxygenase type 2.

Flores AM, Li L, McHugh NG, Aneskievich BJ.

Chem Biol Interact. 2005 Jan 15;151(2):121-32.

PMID:
15698583
19.

Isolation and functional analysis of a keratinocyte-derived, ligand-regulated nuclear receptor comodulator.

Flores AM, Li L, Aneskievich BJ.

J Invest Dermatol. 2004 Dec;123(6):1092-101.

20.

Keratinocyte transient transfections.

Flores AM, Aneskievich BJ.

Methods Mol Biol. 2005;289:263-72.

PMID:
15502191
21.

FHL2 expression in keratinocytes and transcriptional effect on PPARalpha/RXRalpha.

Ciarlo JD, Flores AM, McHugh NG, Aneskievich BJ.

J Dermatol Sci. 2004 Jun;35(1):61-3. No abstract available.

PMID:
15194148
22.

Deletion of RAR carboxyl terminus reveals promoter- and receptor-specific AF-1 effects.

Aneskievich BJ.

Biochem Biophys Res Commun. 2001 Dec 21;289(5):950-6.

PMID:
11741282
23.

The cytoskeletal/non-muscle isoform of alpha-actinin is phosphorylated on its actin-binding domain by the focal adhesion kinase.

Izaguirre G, Aguirre L, Hu YP, Lee HY, Schlaepfer DD, Aneskievich BJ, Haimovich B.

J Biol Chem. 2001 Aug 3;276(31):28676-85. Epub 2001 May 21.

24.
25.
27.

Phosphorylation of integrin in differentiating ts-Rous sarcoma virus-infected myogenic cells.

Aneskievich BJ, Haimovich B, Boettiger D.

Oncogene. 1991 Aug;6(8):1381-90.

PMID:
1653410
29.

Analysis of adenovirus early and late gene expression in cultured epidermal keratinocytes.

Aneskievich BJ, Lee JI, Taichman LB.

J Invest Dermatol. 1990 Feb;94(2):183-6.

31.

Epithelium-specific response of cultured keratinocytes to infection with adenovirus type 2.

Aneskievich BJ, Taichman LB.

J Invest Dermatol. 1988 Oct;91(4):309-14.

Supplemental Content

Loading ...
Support Center